elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38044449-015B33FB-25C2-499C-9E45-D0F582DB50D2
Q38044449-015B33FB-25C2-499C-9E45-D0F582DB50D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38044449-015B33FB-25C2-499C-9E45-D0F582DB50D2
Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology.
P2860
Q38044449-015B33FB-25C2-499C-9E45-D0F582DB50D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38044449-015B33FB-25C2-499C-9E45-D0F582DB50D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8377edacfdffdcaeabfb5209bc81fb80b2b21c7
P2860
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.